A systematic evaluation of environmental and genetic factors associated with incidence and mortality of prostate, lung, colorectal and ovarian cancer.
The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial is a randomized, controlled trial enrolling around 155,000 participants between November 1993 and July 2001, providing a comprehensive dataset for lung cancer incidence and mortality analysis. In addition, diet and behavioral information is also available in questionnaires, such as Baseline Questionnaire (BQ), Dietary Questionnaire (DQX) and Supplemental Questionnaire (SQX). Moreover, the biosamples collected in PLCO also provide a broad base for serum biomarker and genetic data generation for systematic association study.
1) We plan to systematically evaluate the associations between environmental factors (including long-term dietary habits, nutrient supplements, physical activity and sleep conditions) and the incidence and mortality of prostate, lung, colorectal and ovarian cancer.
2) If serum biomarkers data (such as the ovarian biomarkers) are available, we plan to include the serum biomarkers into the systematic evaluation of the risk and survival of prostate, lung, colorectal and ovarian cancer.
3) Since genetic data is also accessible, we plan to investigate the role of genetic variation (as a main effect or interaction with diet and other behavioral factors) in the risk and survival of prostate, lung, colorectal and ovarian cancer.
Jun Tao The University of Hong Kong
-
Role of dietary carbohydrates on risk of lung cancer.
Tao J, Jatoi A, Crawford J, Lam WWT, Ho JC, Wang X, Pang H
Lung Cancer. 2021 Mar 17; Volume 155: Pages 87-93 PUBMED